|
Choose a suitable interchangeable generic or brand drug, if you could not find the prescribed medicine.
We do not sell drugs. This site contains prices only for information purposes to help you buy drugs cheaply.
You should consult a doctor about the dosage before using this medicine!
Description and uses | Sort by popularity |
Betnesol - Betnesol is a moderately potent glucocorticoid steroid with anti-inflammatory and immunosuppressive properties. Unlike other drugs with these effects, Betnesol does not cause water retention. It is applied as a topical cream, ointment, foam, lotion or gel to treat itching (e.g. from eczema). Betnesol sodium phosphate is sometimes prescribed as an intramuscular injection (I.M) for itching from various ailments including allergic reactions to poison ivy and similar plants.
The compound is available as a number of ester derivatives: Betnesol dipropionate (branded as Diprosone, Diprolene and others), sodium phosphate and valerate (branded as Betnovate, Celestone and others).
Betnesol helps relieve inflammation and itch that may occur with certain skin problems and allergies. It is also used to relieve pain in arthritic joints, fluid retention in head injuries, treat inflammatory bowel disease and to control asthma. Betnesol may also be used to prevent organ transplant rejection after a transplant. Betnesol may be used for other purposes as decided by your doctor. Betnesol belongs to a group of medicines called steroids.
Indications: inflammatory bowel disease
Indications: corticosteroid, inflammatory disorders of the eye, ear, or nose
Indications: inflammatory eye, ear, or nose disorders
Indications: inflammation of oral mucous membranes, hypersensitivity reactions, lichen, pemphigoid
Indications: ulcerative colitis
Allergic StatesControl of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic DiseasesBullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).Endocrine DisordersCongenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. Hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency. Synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. Gastrointestinal DiseasesTo tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. Hematologic DisordersAcquired (autoimmune) hemolytic anemia, Diamond-Blackfan anemia, pure red cell aplasia, selected cases of secondary thrombocytopenia. Miscellaneous Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy. Neoplastic DiseasesFor palliative management of leukemias and lymphomas. Nervous SystemAcute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor or craniotomy. Ophthalmic DiseasesSympathetic ophthalmia, temporal arteritis, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal DiseasesTo induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory DiseasesBerylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus. The intra-articular or soft tissue administration of Injectable Suspension is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis. The intralesional administration of Injectable Suspension is indicated for alopecia areata; discoid lupus erythematosus; keloids; localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques; necrobiosis lipoidica diabeticorum. Injectable Suspension may also be useful in cystic tumors of an aponeurosis or tendon (ganglia |
| Active ingredients: Betamethasone |
| Unit description, dosage | Price, USD |
| Injectable; Injection; Betamethasone Sodium Phosphate 4 mg / ml | |
| Ointment; Ophthalmic; Betamethasone Sodium Phosphate 0.1% | |
| Pastilles; Oral; Betamethasone | |
| Solution; Nasal; Betamethasone Sodium Phosphate 0.1% | |
| Solution; Ophthalmic; Betamethasone Sodium Phosphate 0.1% | |
| Solution; Otic; Betamethasone Sodium Phosphate 0.1% | |
| Solution; Rectal; Betamethasone Sodium Phosphate 5 mg / 100 ml | |
| Tablet, Effervescent; Oral; Betamethasone 0.5 mg | |
| Tablet; Oral; Betamethasone 0.5 mg | |
| Tablet; Topical; Betamethasone Sodium Phosphate 0.1 mg | |
| BETNESOL Capsule/ Tablet / 0.5mg (10 units) | $ 0.08 |
| BETNESOL Injection / 4mg (1ml units) | $ 0.09 |
| BETNESOL Capsule/ Tablet / 1mg (10 units) | $ 0.15 |
| BETNESOL Drops / 0.5mg per ml (15ml units) | $ 0.37 |
| Betnesol 1mg FC-TAB / 10 | $ 0.15 |
| Betnesol 0.5mg TAB / 20 | $ 0.12 |
| Betnesol 0.5mg/ml DPS / 15ml | $ 0.18 |
| Betnesol 4mg/ml AMP / 1ml | $ 0.08 |
| 0.5 mg x 20's | $ 0.12 |
| 1 mg x 10's | $ 0.15 |
| 4 mg x 1 mL x 1ml | $ 0.08 |
| 0.5 mg x 1 mL x 15ml | $ 0.18 |
| Tablets, Effervescent; Oral; Betamethasone 0.5 mg | |
| Tablets, Film-Coated; Oral; Betamethasone 1 mg | |
| Tablets; Oral; Betamethasone 0.5 mg | |
| Tablets; Topical; Betamethasone Sodium Phosphate 0.1 mg | |
|
List of interchangeable brands or generic drugs |
| Betnelan-V |
| Betnesol DPS (India) |
| Betnesol DPS 0.1% w/v EYE/EAR DPS / 5ml | $ 0.16 |
| 0.1 % w/v x 5ml | $ 0.16 |
| Betnesol Eye Oint (India) |
| Betnesol Eye Oint 0.1% w/w DYE OINT / 5g | $ 0.10 |
| 0.1 % w/w x 5g | $ 0.10 |
| Betnesol Forte (India) |
| Betnesol Forte 1mg TAB / 10 | $ 0.11 |
| 1 mg x 10's | $ 0.11 |
| Betnesol Retention Enema |
| Enema; Rectal; Betamethasone Sodium Phosphate 5 mg / 100 ml | |
| Betnesol-V (Germany) |
| Betnesol-WL |
| Betneval (France) |
| Cream; Topical; Betamethasone Valerate 0.1% | |
| Lotion; Topical; Betamethasone Valerate 0.1% | |
| Ointment; Topical; Betamethasone Valerate 0.1% | |
| Betneval 0.1 % x 1 oáng 30g | |
| Betnevate (Japan) |
| Betni (India) |
| Betni 4mg TAB / 10 | $ 0.06 |
| Betni 4mg x 1mL INJ / 1ml | $ 0.08 |
| 4 mg x 10's | $ 0.06 |
| 4 mg x 1 mL x 1ml | $ 0.08 |
| Betnolon |
| Betnosone |
| Betnovat (Denmark, Finland, Iceland, Norway, Sweden) |
| Cream; Topical; Betamethasone Valerate 0.1% | |
| Lotion; Topical; Betamethasone Valerate 0.1% | |
| Ointment; Topical; Betamethasone Valerate 0.1% | |
| Solution; Topical; Betamethasone Valerate 0.1% | |
| Betnovate (Antigua & Barbuda, Argentina, Aruba, Australia, Austria, Bahamas, Bahrain, Bangladesh, Barbados, Bermuda, Bosnia & Herzegowina, Bulgaria, Cayman Islands, Colombia, Costa Rica, Czech Republic, Dominican Republic, El Salvador, Estonia, Ethiopia, Greece, Grenada, Guatemala, Guyana, Honduras, Hong Kong, India, Iran, Ireland, Jamaica, Kuwait, Lithuania, Malta, Mexico, Netherlands Antilles, New Zealand, Nicaragua, Oman, Panama, Peru, Philippines, Poland, Portugal, Qatar, Saint Lucia, Singapore, South Africa, Spain, Sri Lanka, Switzerland, Thailand, Trinidad & Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela, Vietnam) |
| Cream; Topical; Betamethasone Valerate 0.1% | |
| Lotion; Topical; Betamethasone Valerate 0.1% | |
| Ointment; Topical; Betamethasone Valerate 0.1% | |
| Solution; Topical; Betamethasone Valerate 0.1% | |
| BETNOVATE Cream/ Gel/ Ointment / 0.12(%) (20gm units) | $ 0.33 |
| Betnovate 0.1 % x 15 g | $ 6.35 |
| Betnovate 0.1 % x 30 mL | $ 15.82 |
| Betnovate 0.1% w/w CRM / 20g | $ 0.33 |
| Betnovate 0.1 % x 5 g x 1's | |
| Betnovate 0.1 % x 100 g | |
| Betnovate 0.1 % x 15 g x 1's | |
| Betnovate RD 0.025 % x 15 g x 1's | |
| Betnovate 1 mg/1 mL x 20 mL | $ 11.20 |
| Betnovate 1 mg/1 g x 5 g | $ 5.25 |
| Betnovate 1 tuyùp 20 g | |
| 0.1 % w/w x 20g | $ 0.33 |
| Betnovate 0.1 % x 1 tuyùp 20 g | |
|
Show all Betnesol generic names
|
|
|
|